Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Goss

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Pharmacology|December 1, 1994
Pharmacodynamics of bolus famotidine versus infused cimetidine, ranitidine, and famotidineG W Amsden, T F Goss, N J Harrison, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patientsA Forrest, D E Nix, C H Ballow, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1991
Effects of ranitidine and sucralfate on ketoconazole bioavailabilityS C Piscitelli, T F Goss, J H Wilton, et al.
Health Services Research|August 1, 1997
Comparison of responses to SF-36 Health Survey questions with one-week and four-week recall periodsS D Keller, M S Bayliss, J E Ware, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 19, 1998
The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adultsJ E Ware, J P Kemp, D A Buchner, et al.
Clinical Cardiology|August 15, 2001
Development and validation of the ITG Health-Related Quality-of-Life Short-Form measure for use in patients with coronary artery disease. Integrated Therapeutics GroupD A Buchner, T B Graboys, K Johnson, et al.
The Annals of Pharmacotherapy|July 1, 1994
Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoximeT F Goss, A Forrest, D E Nix, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Pharmacology|December 1, 1994
Pharmacodynamics of bolus famotidine versus infused cimetidine, ranitidine, and famotidineG W Amsden, T F Goss, N J Harrison, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patientsA Forrest, D E Nix, C H Ballow, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1991
Effects of ranitidine and sucralfate on ketoconazole bioavailabilityS C Piscitelli, T F Goss, J H Wilton, et al.
Health Services Research|August 1, 1997
Comparison of responses to SF-36 Health Survey questions with one-week and four-week recall periodsS D Keller, M S Bayliss, J E Ware, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 19, 1998
The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adultsJ E Ware, J P Kemp, D A Buchner, et al.
Clinical Cardiology|August 15, 2001
Development and validation of the ITG Health-Related Quality-of-Life Short-Form measure for use in patients with coronary artery disease. Integrated Therapeutics GroupD A Buchner, T B Graboys, K Johnson, et al.
The Annals of Pharmacotherapy|July 1, 1994
Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoximeT F Goss, A Forrest, D E Nix, et al.
Pageof 2